Stay updated on KarXT Long-Term Safety in Schizophrenia Clinical Trial
Sign up to get notified when there's something new on the KarXT Long-Term Safety in Schizophrenia Clinical Trial page.

Latest updates to the KarXT Long-Term Safety in Schizophrenia Clinical Trial page
- Check7 days agoChange DetectedAn NIH-wide notice about the transition from “Artificial Intelligence” to “Super Intelligence” appears above the existing 403 error page. The displayed site revision changes from v3.7.1 to v3.7.2.SummaryDifference1%

- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedThe site revision identifier changed from v3.7.0 to v3.7.1; the page continues to display a 403 Forbidden error instead of the study record.SummaryDifference0.2%

- Check35 days agoChange DetectedThe study record page now displays a 403 Forbidden error instead of the expected content, replacing the details with a standard error screen. This indicates that access to the record is blocked on the site.SummaryDifference17%

- Check42 days agoChange DetectedThe study page now includes the topic Schizophrenia and related topics MedlinePlus Genetics, and the site revision changed from v3.6.6 to v3.7.0.SummaryDifference0.2%

- Check56 days agoChange DetectedRevision: v3.6.6 was added to the page. The previous Revision: v3.6.5 reference and related topics such as Schizophrenia and MedlinePlus Genetics were removed.SummaryDifference0.2%

- Check70 days agoChange DetectedThe page now adds related topics entries for Schizophrenia and MedlinePlus Genetics to connect readers with additional background resources.SummaryDifference0.1%

Stay in the know with updates to KarXT Long-Term Safety in Schizophrenia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the KarXT Long-Term Safety in Schizophrenia Clinical Trial page.